Qinghai Lukang Dadi Pharmaceutical

Qinghai Lukang Dadi Pharmaceutical Co., Ltd., established in 1997 and headquartered in Xining, Qinghai, China, is a pharmaceutical company specializing in the research, development, manufacturing, and commercialization of traditional Chinese and Tibetan medicines, as well as chemical generic drugs. In November 2011, the company was acquired and became a controlled subsidiary of Shandong Lukang Pharmaceutical Co., Ltd. The company operates modern manufacturing facilities with tablet, capsule, soft capsule, and granule production lines, all certified under China's Good Manufacturing Practice (GMP) standards. Its key commercial products include Shenlu Fuzheng Capsules (参鹿扶正胶囊) for supportive cancer care and general weakness, Paiduxingzhi Capsules (排毒清脂胶囊), and Zangyinchen Tablets (藏茵陈片). Qinghai Lukang Dadi Pharmaceutical leverages the unique natural resources of the high-altitude Qinghai-Tibet Plateau to produce high-quality, affordable healthcare products for the Chinese market.